Concepedia

Charles A. Conrad

CA

Statistics

Publications

67

Citations

7.7K

H-Index

43

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Los Angeles

Memorial Sloan Kettering Cancer Center

National High Magnetic Field Laboratory

National Cancer Institute

Charles A. Conrad is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and glioblastoma.

ORCID

Publications per year

1984–2018

67

Publications

67

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano et al. · Journal of Clinical Oncology · 2018 · 708 citations

, , +17

PD-L1 expression and prognostic impact in glioblastoma

Edjah K. Nduom, Jun Wei, Nasser K. Yaghi et al. · Neuro-Oncology · 2015 · 614 citations

, , +17

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

John de Groot, Gregory N. Fuller, Ashok J. Kumar et al. · Neuro-Oncology · 2010 · 505 citations · Full text

, , +14

A Passion for Excellence: The Leadership Difference.

Charles A. Conrad, Tom Peters, Nancy Austin · Administrative Science Quarterly · 1985 · 456 citations

, , +17

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn et al. · Clinical Cancer Research · 2006 · 432 citations

, , +16

1–5 of 67